Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products.
Financial Results:
Mankind Pharma Ltd reported Revenues for Q3FY25 of ₹2,397.00 Crores up from ₹2,209.00 Crore year on year, a rise of 8.51%.
Total Expenses for Q3FY25 of ₹1,942.00 Crores up from ₹1,730.00 Crores year on year, a rise of 12.25%.
Consolidated Net Profit of ₹416.00 Crores down 14.58% from ₹487.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹10.09, down 17.02% from ₹12.16 in the same quarter of the previous year.
![](data:image/svg+xml;charset=utf-8,<svg height="781px" width="640px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
